1. Clinical Practice Guidelines Group. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126(Suppl):1S 92S This statement ...

Patients continued taking their medications for pulmonary arterial hypertension (PAH) when symptoms appeared to improve, according to a new survey. Professional guidelines say that when pulmonary ...

Looking for reliable medications to treat 'Pulmonary Hypertension'? This page offers a detailed resource for the most up-to-date treatment options, including both generic and brand-name medications.

Men with PAH had a larger right heart size and worse survival than women, independent of body size and functional status, a ...

for WHO group 1 pulmonary hypertension (PH, or PAH) over the course of one week in March, one treatment appears to have had a more successful launch than the other. Sotatercept uptake "has been ...

Considering taking supplements to treat pulmonary hypertension? Below is a list of common natural remedies used to treat or reduce the symptoms of pulmonary hypertension. Follow the links to read ...

Safety of a Potential New Treatment to Manage Complications from Sickle Cell Disease Apr. 11, 2024 — A drug approved to treat pulmonary arterial hypertension may be effective at managing ...

Professor Christopher Denton discusses key aspects of the 2024 British Society for Rheumatology guideline on managing ...

TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with ...

Shares in Keros Therapeutics fell sharply Wednesday morning after it said it halted trials of its treatment for pulmonary hypertension after finding adverse health effects in patients trialing the ...

Keros Therapeutics has halted the dosing of its treatment for pulmonary hypertension due to adverse health effects discovered during trials. The clinical-stage biopharmaceutical company said ...